Summary & Overview
CPT 86978: Serum Absorption for Antibody Preparation
CPT code 86978 designates a laboratory serologic procedure in which serum is treated so a specific antibody is absorbed onto red blood cells to prepare for antibody identification. This technical step is integral to immunohematology workflows, including pretransfusion testing and complex antibody workups, and supports safe transfusion practice and accurate diagnostic interpretation across clinical settings. Nationally, consistent use and correct coding of 86978 affect laboratory billing, quality reporting in blood bank services, and resource planning for hospital and independent labs.
Key payers included in this review are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and common billing modifiers associated with reporting. The publication also outlines benchmarking and reimbursement considerations where available and summarizes relevant policy and coding guidance that influence how 86978 is used in practice. The content is intended to help billing managers, laboratory directors, and compliance personnel understand the clinical purpose of the code, payer coverage landscape, and operational implications for lab workflows. Data not available in the input will be noted where necessary.
Billing Code Overview
CPT code 86978 describes a laboratory procedure in which a lab analyst treats serum to cause a specific antibody to red blood cells (RBCs) to be absorbed onto the surface of the RBCs. This absorption step is performed to prepare the specimen for identification of different serum antibodies. The service type is a specialized serologic preparation and antibody identification procedure.
Typical site of service for CPT code 86978 is a clinical laboratory or hospital laboratory where blood bank and immunohematology testing is performed. The procedure is performed by trained laboratory personnel as part of pretransfusion testing, antibody workups, or immunohematologic investigations.
Clinical & Coding Specifications
Clinical Context
A patient undergoing pre-transfusion testing or evaluation for suspected alloantibodies presents to the hospital blood bank or outpatient laboratory. Typical scenarios include a patient with anemia requiring transfusion, a woman in prenatal care with a positive antibody screen, or a patient with a history of prior transfusions or transplantation who has a newly identified pan- or multiple-reacting antibody on initial serologic testing. The laboratory performs adsorption by treating the patient’s serum with reagent red blood cells to remove (adsorb) specific antibodies from the serum before performing antibody identification panels. This process clarifies the specificity of remaining antibodies, identifies underlying clinically significant alloantibodies, and guides selection of compatible blood units.
The clinical workflow: a specimen is collected and received in the immunohematology laboratory; an antibody screen or panel demonstrates reactivity that interferes with interpretation; the technologist documents patient transfusion and pregnancy history, selects appropriate adsorbing cells (autologous, allogeneic, enzyme-treated, or selected phenotype cells), performs the adsorption procedure per established protocols, and then repeats antibody identification testing on the adsorbed serum. Results are reviewed by a blood bank specialist (often a clinical laboratory scientist or pathologist with transfusion medicine expertise) and reported to the ordering clinician and transfusion service to inform crossmatching and blood product selection.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |